NNNNNNNNNNNNNNNN
SEAnews SEA Research, BLK 758 Yishun Street 72 #09-444 Singapore 760758
India Front Line Report
SEAnews Issue:monthly
tel:65-87221054
NNNNNNNNNNNNNNN
2013-08-16 ArtNo.44590
◆Jubilant Life sees cancer drug trials by end-2013
Jubilant Life Sciences Limited said late on Wednesday its new drug aimed at treating prostate cancer is expected to enter clinical trials by the end of this year in the United States.
US based Endo Pharmaceuticals Inc and Jubilant's Bangalore unit are jointly developing the drug. The US Food and Drug Administration has accepted the filing for this investigational new drug application, Jubilant said in a statement.
【News source】

Jubilant Life sees cancer drug trials by end-2013

Your Comments


[Your Comments / Unsubscribe]/[您的意见/退订]/[ご意見/配信停止]
Please do not directly reply to the e-mail address which is used for delivering the newsletter.
请别用递送新闻的邮件地址而直接回信。
メールをお届けした送信専用アドレスには返信しないで下さい。
SEAnews 掲載記事の無断転載を禁じます。すべての内容は日本の著作権法並びに国際条約により保護されています。
Copyright 2003 SEAnews® All rights reserved. No reproduction or republication without written permission.